- Using a combination of advanced MRI sensors and powerful Vertical AI, Orbem’s solutions reveal what we can’t see on the outside of biological materials, enabling high-tempo, non-invasive analysis.
- The Munich-based company has now received €55.5 million in a Series B financing round led by European Deep tech investors Innovation Industries and joined by Supernova Invest as well as existing investors.
- The new capital will fuel Orbem’s entry into the US market, scale its proven solutions in the poultry industry, and expand its actionable intelligence to new challenges in food and human healthcare.
Orbem, the Munich-based Deep tech company turning Magnetic Resonance Imaging (MRI) into a powerful, AI-powered tool to reveal hidden insights in food and biology, today announced the successful closing of a €55.5 million Series B financing round. The round is led by European Deep tech specialist Innovation Industries and joined by Supernova Invest, with significant follow-on participation from existing investors General Catalyst, 83North, The Venture Collective, Possible Ventures, and several angel investors.
Orbem has developed a breakthrough platform that makes MRI technology fast, affordable and scalable, enabling non-invasive analysis of biological materials at an industrial scale. By doing so, the company is building what is becoming the industry's largest and most comprehensive biological dataset. Already profitable and a leading provider of in-ovo sexing in five European countries, a position built on its deep understanding of poultry industry processes, Orbem will use the new capital to fuel its expansion into the United States, launch new solutions for the poultry industry, and enter the multi-billion-dollar fruit and vegetable market. Additionally, Orbem will invest in its vision to apply its actionable intelligence to human healthcare.
Proven Success: Transparency in the Poultry Industry
Orbem has already delivered measurable impact in the poultry industry, leveraging its deep industry process knowledge to deliver practical solutions. Its flagship product, the Genus Focus, uses AI-powered MRI to see inside a poultry egg, non-invasively determining its sex in less than one second. This provides an animal-friendly and highly efficient alternative to the culling of male chicks, a practice now banned in several EU countries. With over 170 million eggs scanned to date, Orbem is scaling rapidly, ready to meet increasing global demand spurred by initiatives like the new ‘Hatch Check’ certification in the US.
Building on this success, Orbem recently launched the Genus Scale, a first-of-its-kind product that sees inside eggs to check their fertilization status before incubation. This allows hatcheries to stop wasting valuable incubator space on non-viable eggs, repurposing them for the food industry, creating new revenue streams, and fighting food waste.
A New Era of Growth: Scaling and Expansion
The Series B funding will accelerate Orbem's mission to solve global challenges by revealing what we can’t see on the outside of food and biology. Key initiatives include:
- US Market Entry: After establishing its first US office in Houston, Texas, in 2025, Orbem is bringing its proven poultry solutions to one of the world's largest agricultural markets.
- Expanded Poultry Platform: Orbem will continue to strengthen its commitment to the poultry industry, scaling its existing solutions.
- New Vertical: Fruits & Vegetables: The company is expanding its actionable intelligence for sustainable food production into the fruit and vegetable sector. Orbem’s non-destructive technology can see inside produce like watermelons, avocados and mangoes to spot internal defects and assess quality without cutting them open. This helps producers to sort goods with precision, ensure consistent quality, and dramatically reduce food waste before products reach the consumer.
- Healthcare: What Orbem learns from scanning millions of eggs and avocados translates to a deeper understanding of biology. The company is building the world's largest biological dataset. This unique asset is the foundation for AI models that will have profound applications in human health, making non-invasive insights more accessible.
Dr. Pedro Gómez, co-founder and CEO of Orbem, says: “We’re the first and so far only company in the world to demonstrate the use of MRI in less than one second and without humans in the loop. We began by showing the poultry industry what’s possible when you can see inside an egg, and we are just getting started. This new funding allows us to accelerate our US expansion and help more food producers and healthcare providers make better decisions with data. Our scalable platform and our rapidly growing, proprietary biological dataset are the perfect basis for achieving this. We are proud to see the trust our investors have placed in us and our vision to help the world see from the inside out.”
Pleuni Hooijman, Investment Manager at Innovation Industries, states: “Orbem is truly exceptional. Few companies manage to make such complex technology accessible and scalable across so many industries. With its platform, Orbem is already transforming entire sectors, and we are very pleased to join them on this journey.“
Michaël Thomas, Investment Director at Supernova Invest, adds: "We’re thrilled to join forces with Orbem, a visionary company that perfectly embodies Europe’s Deep tech excellence. By combining cutting-edge AI and MRI technologies, Orbem delivers concrete answers to some of the major challenges of our time, from reducing animal suffering to fighting food waste and building a more sustainable global food system. This investment illustrates our conviction that Europe can lead in physical AI, transforming scientific breakthroughs into meaningful industrial innovation."
About Orbem - The Inside Out Company
Orbem uses AI to industrialize MRI, enabling non-invasive insight into everything from fruits to eggs to the human body. Translating what is becoming the world’s largest biological dataset into actionable intelligence, the company helps food producers, researchers, and other innovators make better decisions. By providing them with previously inaccessible information – the sex of an embryo inside an egg, the health of a seed, the quality of an avocado without cutting it open – Orbem serves global customers across agriculture, food, and health. Their high-tempo, non-destructive insights, grounded in a deep understanding of industry processes such as in poultry, reduce waste, increase quality and transparency, and accelerate the shift towards a more sustainable and healthier future.
Headquartered in Munich, Germany, with offices in Houston, Texas, Orbem’s team scales its inside-out intelligence to transform the way humanity sees and understands biological matter.
Media contact: barbara.jilek@orbem.ai
About Innovation Industries
Innovation Industries is a leading European Deep tech venture capital firm with €1 billion in capital under management. The firm invests in visionary science and engineering-based companies that tackle the world’s most pressing challenges. With a strong belief that Deep tech can deliver both outsized financial returns and global impact, Innovation Industries partners with exceptional entrepreneurs and researchers to turn scientific breakthroughs into transformative companies. The firm provides long-term capital and strategic support from lab to scale, actively bridging the gap between academia and industry through close collaboration with leading technical universities, research institutions and industry partners. Innovation Industries has offices in Amsterdam, Eindhoven and Munich.
https://www.innovationindustries.com/
About Supernova Invest
Supernova Invest is the leading Deep Tech Venture Capital firm in Europe and manages ca. €800 million in assets. The current portfolio includes 80+ innovative and impact-driven companies that develop products and services leveraging breakthrough technologies in four transition-centric sectors: Cleantech, Digital, Industrial Technologies, and Healthcare. For 20 years, Supernova Invest has been providing long-term capital, operating experience, and strategic support to back the sustainable growth of tomorrow’s Deep tech and industrial champions throughout the Venture Capital life cycle: seed, early, late, and growth stages. Supernova Invest also gathers the entire Deep tech value chain to support portfolio companies: corporates, research institutions, and co-investors.
Supernova Invest is backed by both Amundi, the largest asset manager in Europe, and CEA, the most innovative public research organization in Europe.
Media contact: supernovainvest@vae-solis.com
.avif)
